Download presentation
Presentation is loading. Please wait.
Published byShona Patrick Modified over 9 years ago
1
MRCPsych addiction psychiatry seminar series Policy, guidance and legal framework of addiction treatment Classification of substance use disorders Assessment Epidemiology of addictive disorder and their natural history Dr Stuart McLaren 2 nd March 2012
2
The policy approach Harm reduction versus abstinence Recovery movement
3
Recent NICE guidance Technology appraisals: –methadone, –buprenorphine –naltrexone Drug misuse clinical guidelines: –opioid detoxification (CG 52) –psychosocial interventions (CG 51) Alcohol-use disorders: –management of alcohol-related physical complications (CG 115) –diagnosis, assessment and management of harmful drinking and alcohol dependence (CG 100)
4
Department of Health guidelines 2007 Drug misuse and dependence: UK guidelines on clinical management ‘the orange book’
5
Misuse of Drugs Act 1971 and Regulations 2001 Class A – cocaine, ecstasy, heroin, LSD, methadone, Class B drugs injected Class B – amphetamines, barbiturates, codeine Class C – anabolic steroids, minor tranquillisers, cannabis
6
Regulations Schedule 1 – no therapeutic value (cannabis,LSD) Schedule 2 & 3 – can be prescribed (heroin, amphetamine, temazepam) Schedule 4 – can be prescribed (mostly benzodiazepines) Schedule 5 – over the counter medications
7
Implications Doctors can prescribe: Amphetamines Barbiturates Cocaine** Heroin** Methadone ** need HO license to prescribe to ‘addicts’
8
Mental Health Act 2007 No change! Exclusion of drug and alcohol dependency was retained F1x.4 withdrawal state with delirium F1x.5 psychotic disorder F1x.6 amnesic disorder F1x.7 residual and late-onset psychotic disorder
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.